PFIZER marked World Metastatic
Breast Cancer Day earlier this week
with the further commitment of
$300,000 in funding over three
years to the McGrath Foundation.
The money will fund a dedicated
Metastatic Breast Cancer nurse,
with McGrath Foundation ceo Petra
Buchanan saying the needs for
patients with metastatic disease are
quite different.
Approximately 30% of primary
breast cancer patients will develop
secondaries, while 6% will be
metastatic at diagnosis.
The median survival rate
following a metastatic breast
cancer diagnosis is just three years,
with an estimated 9,000 women
currently living with secondary
breast cancer in Australia.
Representatives from Pfizer
handed over a giant novelty cheque
to the McGrath Foundation at an event in
Sydney on Wednesday.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Oct 15
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.